Financial News Feed

Weaker Buy Today AGIO ranks #757 as BUY CANDIDATE. Stronger Buy
Today AGIO ranks #757 as BUY CANDIDATE.

AGIO stock Agios Pharmaceuticals

AGIO stock
Agios Pharmaceuticals

Both Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Dare Bioscience Inc. (NASDAQ:DARE) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to ...

Read more

Bourgeon Capital Management Llc increased Eaton Corp Plc (ETN) stake by 17.22% reported in 2018Q4 SEC filing. Bourgeon Capital Management Llc acquired 8,400 Sentiment for Agios Pharmaceuticals Inc (AG...

Read more

Traders may be watching short-term indicators on shares of Agios Pharmaceutical (AGIO). Currently, the 7-day average directional indicator is Sell. This signal may be used to determine the market tren...

Read more

Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) and Agios Pharmaceuticals Inc. (NASDAQ:AGIO) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, analyst ...

Read more

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares have moved -3.22% on the week. The stock closed the most recent session at $62.75 after seeing 268863 shares trade hands. This represents a change of 0...

Read more

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) currently have an average target price of $95.67. This is the consensus number using estimates provided by polled analysts. Street analysts often gi...

Read more

We are comparing Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Outlook Therapeutics Inc. (NASDAQ:OTLK) on their institutional ownership, profitability, risk,...

Read more

Both Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) and Agios Pharmaceuticals Inc. (NASDAQ:AGIO) compete on a level playing field in the Biotechnology...

Read more

Both Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH) are Biotechnology companies, competing one another. We will...

Read more

Both Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with rega...

Read more

This is a contrast between Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) based on their risk, institutional ownership,...

Read more

Both Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Liquidia Technologies Inc. (NASDAQ:LQDA) are each other’s competitor in the Biotechnology industry. Thus the...

Read more

Among 2 analysts covering Agios Pharma (NASDAQ:AGIO), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Agios Pharma had 6 analyst reports since February 15, 2019 according to SRating...

Read more

The Price to Cash Flow for Agios Pharmaceuticals, Inc. (NasdaqGS:AGIO) is -11.948750. The price to cash flow formula is a useful tool investors can use in order to determine the value of a company. Ge...

Read more

We will be comparing the differences between Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and Tocagen Inc. (NASDAQ:TOCA) as far as profitability, analyst recommendations, risk, institutional ownership, di...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank